PSA screening reduces prostate cancer deaths by 30%
— January 23, 2019PSA-screening cuts deaths from prostate cancer by some 30%. This is shown by research based on data on 20,000 men monitored for more than two decades. The men’s initially measured PSA level proved highly significant as a predictor of future cancer risk. “This research is important because it shows the long-term effects of an organized […]
Continue Reading ...